The activation of STAT3 determines the sensitivity of cervical cancer cells to TRAIL-induced apoptosis and can be abrogated by inhibiting the Janus kinase 2 (JAK2), which phosphorylates STAT3 [62,63]. This evidence concerns the gene JAK2 and cervical carcinoma.